LIVE BLOG24 Aug 2026 | 09:37:31 AM ISTIPO Updates todaySynopsisIPO GMP Live Updates: Symbiotec Pharmalab and Skyways Air Services IPOs open August 24, featuring 41% and 23% GMPs. Investors can assess pharmaceutical and logistics growth prospects alongside valuations, financials, and risks.Symbiotec Pharmalab and Skyways Air Services IPOs open for subscription on August 24, 2026, attracting strong investor interest with grey-market premiums of around 41% and 23%, respectively. Symbiotec’s Rs 1,757 crore issue offers exposure to specialised APIs, CDMO services, biotechnology and pharmaceutical manufacturing, supported by international regulatory approvals. Skyways Air Services’ Rs 582.8 crore IPO focuses on air freight forwarding and integrated logistics, with proceeds partly earmarked for debt repayment and working capital. Both companies operate in growing sectors and have reported healthy business performance. However, investors should evaluate valuations, financials, business risks, GMP volatility and long-term growth prospects before subscribing. Show more Show less1 New UpdateHorizon Industrial Parks IPO GMP Live | Horizon Industrial Parks shares to list todayShares of Horizon Industrial Parks are scheduled to list on the BSE and NSE today, August 24. Ahead of the debut, grey market sentiment remains cautious, with the IPO commanding a GMP of around ₹2, or nearly 3% over its issue price of ₹60. The premium points to a potentially positive, but largely muted, listing for the shares.Tempsens Instruments IPO Day 3: GMP at 105%, subscription hits 21.66x. Should you subscribe?Tempsens Instruments IPO entered its third and final day of bidding on August 24, drawing strong investor interest. The issue is reportedly commanding a grey market premium (GMP) of 105%, signalling expectations of a robust listing and potentially strong debut gains.Hy-Tech Engineers IPO GMP Live: Objects of the IssueThe company plans to use the net proceeds primarily for capital expenditure of ₹29.97 crore, including the purchase of machinery and equipment for expansion at its Kavathe and Shirwal units, as well as procurement for Pithampur Unit-I.Another ₹16 crore will be utilised for the full or partial prepayment or repayment of certain outstanding borrowings, while the remaining funds will be allocated towards general corporate purposes. Overall, the company expects to deploy ₹45.97 crore from the issue proceeds.Hy-Tech Engineers IPO GMP Live: Hy-Tech Engineers signals 47% listing premium. Should you subscribe?Hy-Tech Engineers IPO opens for subscription today, August 24, giving investors a three-day window to place their bids. The key focus ahead of the issue opening is the grey market premium (GMP), which currently points to a potential 47% premium over the IPO price, signalling strong expectations for the stock’s listing.Skyways Air IPO GMP Live | Grey market signals 23% premiumThe Skyways Air IPO is currently commanding a grey market premium (GMP) of Rs 32, or around 23%, over its upper price band of Rs 138 per share. Based on the latest GMP, the IPO’s estimated listing price is around Rs 170 per share, suggesting a potential listing gain of about 23% over the issue price.Symbiotec Pharmalab IPO GMP Live | About Symbiotec PharmalabSymbiotec Pharmalab has specialised capabilities in APIs, CDMO services and complex pharmaceutical manufacturing. Its backward-integrated operations and international regulatory approvals could support its long-term growth.Symbiotec Pharmalab IPO GMP Live | Grey market signals 41% premiumThe IPO is commanding a grey-market premium of around Rs 409, or approximately 41%, over the upper price band of Rs 988. At the prevailing GMP, the estimated listing price works out to around Rs 1,397 per share. However, grey-market premiums are unofficial indicators and can change before listing.Symbiotec Pharmalab IPO GMP Live | Symbiotec Pharmalab IPO price bandThe company has fixed the IPO price band at Rs 938–Rs 988 per share. The issue will remain open from August 24 to August 27.Investors can bid for a minimum of 15 shares, with subsequent bids in multiples of 15. At the upper end of the price band, the minimum investment requirement is Rs 14,820.The shares are proposed to list on both the BSE and NSE. IPO allotment is expected to be finalised on August 28, with the tentative listing date set for September 1.Symbiotec Pharmalab IPO GMP Live | Check Price Band, GMP, Issue Size and Listing DateThe much-awaited Symbiotec Pharmalab IPO opens for subscription on August 24, 2026, giving investors an opportunity to participate in the public offering of the biopharmaceutical and biotechnology company.The company plans to raise Rs 1,757 crore through the IPO. The issue consists of a fresh issue of 15 lakh shares worth Rs 150 crore and an offer for sale (OFS) of 1.63 crore shares aggregating Rs 1,607 crore.